183 related articles for article (PubMed ID: 37735389)
1. Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.
Liu CH; Lin CY; Huang BS; Wei YC; Chang TY; Yeh CH; Sung PS; Jiang JL; Lin LY; Chang JT; Fan KH
Radiat Oncol; 2023 Sep; 18(1):155. PubMed ID: 37735389
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
3. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
[TBL] [Abstract][Full Text] [Related]
4. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
Mao YP; Zhou GQ; Liu LZ; Guo R; Sun Y; Li L; Lin AH; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Ma J
Br J Cancer; 2014 May; 110(11):2633-9. PubMed ID: 24809780
[TBL] [Abstract][Full Text] [Related]
6. Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy.
Wu VWC; Tam SY
Radiat Oncol; 2020 May; 15(1):112. PubMed ID: 32414378
[TBL] [Abstract][Full Text] [Related]
7. Head and Neck Cancer Types and Risks of Cervical-Cranial Vascular Complications within 5 Years after Radiation Therapy.
Liu CH; Huang BS; Lin CY; Yeh CH; Lee TH; Wu HC; Chang CH; Chang TY; Huang KL; Jiang JL; Chang JT; Chang YJ
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887557
[TBL] [Abstract][Full Text] [Related]
8. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
[TBL] [Abstract][Full Text] [Related]
9. Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.
Kitpanit S; Lee A; Pitter KL; Fan D; Chow JCH; Neal B; Han Z; Fox P; Sine K; Mah D; Dunn LA; Sherman EJ; Michel L; Ganly I; Wong RJ; Boyle JO; Cohen MA; Singh B; Brennan CW; Gavrilovic IT; Hatzoglou V; O'Malley B; Zakeri K; Yu Y; Chen L; Gelblum DY; Kang JJ; McBride SM; Tsai CJ; Riaz N; Lee NY
Int J Part Ther; 2020; 6(4):17-28. PubMed ID: 32582816
[TBL] [Abstract][Full Text] [Related]
10. A study of radiation-induced cerebral vascular injury in nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
Ye J; Rong X; Xiang Y; Xing Y; Tang Y
PLoS One; 2012; 7(8):e42890. PubMed ID: 22912759
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
[TBL] [Abstract][Full Text] [Related]
12. The effect of primary tumor volume on the prognosis of nasopharyngeal carcinoma in era of volumetric modulated arc therapy: a propensity score matched cohort study.
Lin X; Wang B; Zheng F; Fei Z; Chen C
Braz J Otorhinolaryngol; 2023; 89(3):374-382. PubMed ID: 37105031
[TBL] [Abstract][Full Text] [Related]
13. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer.
Engeseth GM; Hysing LB; Yepes P; Pettersen HES; Mohan R; Fuller CD; Stokkevåg CH; Wu R; Zhang X; Frank SJ; Gunn GB
Acta Oncol; 2022 Feb; 61(2):215-222. PubMed ID: 34534047
[TBL] [Abstract][Full Text] [Related]
14. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
16.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy.
Wang J; Miao Y; Ou X; Wang X; He X; Shen C; Ying H; Hu W; Hu C
Radiat Oncol; 2019 Mar; 14(1):42. PubMed ID: 30866964
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study.
Liu L; Fei Z; Chen M; Zhao L; Su H; Gu D; Lin B; Cai X; Lu L; Gao M; Ye X; Jin X; Xie C
Radiat Oncol; 2018 Aug; 13(1):148. PubMed ID: 30103765
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Relevance of Change in Body Mass Index in Patients With Nasopharyngeal Carcinoma Undergoing Volumetric Modulated Arc Therapy: A Retrospective Study.
Lin X; Wang B; Zheng F; Fei Z; Chen C
Cancer Control; 2022; 29():10732748221126935. PubMed ID: 36075003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
